- Home
- SLNH vs KZR Comparison
SLNH vs KZR Comparison
Compare SLNH & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNH | KZR |
|---|---|---|
| Founded | 1961 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.8M | 45.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SLNH | KZR |
|---|---|---|
| Price | $1.53 | $6.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 5.4M | 30.6K |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,782,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.36 | $3.53 |
| 52 Week High | $5.14 | $6.95 |
Technical Indicators
Market Signals| Indicator | SLNH | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 62.27 |
| Support Level | $1.25 | $6.22 |
| Resistance Level | $1.65 | $6.38 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 27.88 | 81.82 |
Price Performance
Historical ComparisonAbout SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.